Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth Renews, Expands License to Ingenuity's Pathway Analysis Software

NEW YORK  (GenomeWeb News) — Ingenuity Systems today said that Wyeth Pharmaceuticals has extended and expanded a licensing agreement for its Pathway Analysis software.
 
Wyeth’s researchers will use the IPA software to study pharmacogenomic biomarkers and other areas, Ingenuity said.
 
Ingenuity said Wyeth has been using its software since 2003.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more